NCT05731557View on ClinicalTrials.gov

ACE, Resilience, and Substance Use Disorder: Maternal and Baby Outcomes in the First Year of Life

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

June 2, 2024

Study Completion Date

October 5, 2024

Conditions
Adverse Childhood Experiences
Trial Locations (1)

08103

Cooper University Hospital, Camden

All Listed Sponsors
lead

The Cooper Health System

OTHER

NCT05731557 - ACE, Resilience, and Substance Use Disorder: Maternal and Baby Outcomes in the First Year of Life | Biotech Hunter | Biotech Hunter